Momentum Movers, Trader Talk

KalVista Pharmaceuticals (KALV) Climbs 140%

Article Related Press Releases (1) Related Articles (2) Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 4/13/2021

1. NVDA
2. BABA
3. NUAN
4. INTC
5. VEI

6. OLO
7. NAPA
8. IRTC
9. XPEV
10. GME

Top News Most Read Special Reports

Wall Street ends lower as investors await earnings, inflation data
Microsoft (MSFT) announces $19.7 billion acquisition of Nuance (NUAN)
Alibaba (BABA) Gets a Record $2.8 Billion Anti-Monopoly Fine, Shares Soar as a 'Major Overhang' is Lifted
Tesla (TSLA) Upgraded to 'Buy' at Canaccord Genuity and PT Raised by 155%, as it 'Holds a Several-Year Lead' in EV While Storage Business Accelerates
Dollar drops as traders prepare for inflation data

February 9, 2021 7:20 AM EST

Get Alerts KALV Hot Sheet

Price: $25.23 -3.52%

Overall Analyst Rating:
BUY (

Up)

Trade Now!

Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

KalVista Pharmaceuticals (NASDAQ: KALV) Climbs 140%

Earlier KalVista Pharmaceuticals (KALV) Reports Positive Results for KVD900 Phase 2 Demonstrating Statistically and Clinically Significant Responses Across All Endpoints as an Oral On-Demand Treatment for HAE

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Create E-mail Alert Related Categories

Momentum Movers, Trader Talk

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!